Zonghui Ma

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Ulcerative Colitis

Patient Reported Outcomes

Top Venues

Expert opinion on therapeutic targets

Expert opinion on therapeutic patents

This page only lists publications with an associated author ORCID identifier.

Publications

Zonghui Ma, Cun Zhang, Andrew A Bolinger, Jia Zhou
An updated patent review of BRD4 degraders. Expert opinion on therapeutic patents (2024)
Zonghui Ma, Andrew A Bolinger, Jia Zhou, Bing Tian
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics. Expert opinion on therapeutic targets (2023)
Zonghui Ma, Andrew A Bolinger, Jia Zhou, Bing Tian
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics. Expert opinion on therapeutic targets 27 (1) (2023)
Zonghui Ma, Andrew A Bolinger, Jia Zhou, Bing Tian
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics. Expert opinion on therapeutic targets 27 (1) (2023)
Zonghui Ma, Andrew A Bolinger, Jia Zhou, Bing Tian
Bromodomain-containing protein 4 (BRD4): A key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics. Expert opinion on therapeutic targets (2023)
Zonghui Ma, Andrew A Bolinger, Jia Zhou, Bing Tian
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics. Expert opinion on therapeutic targets 27 (1) (2023)